Search Results

There are 6352 results for: content related to: Boceprevir in liver transplant recipients

  1. Use of first-generation HCV protease inhibitors in patients coinfected by HIV and HCV genotype 1

    Liver International

    Volume 34, Issue 6, July 2014, Pages: 869–889, Dominique Salmon-Ceron, Cédric Arvieux, Marc Bourlière, Patrice Cacoub, Philippe Halfon, Karine Lacombe, Georges-Philippe Pageaux, Gilles Pialoux, Lionel Piroth, Isabelle Poizot-Martin, Eric Rosenthal and Stanislas Pol

    Version of Record online : 25 NOV 2013, DOI: 10.1111/liv.12363

  2. You have free access to this content
    Pharmacokinetic interaction between the hepatitis C virus protease inhibitor boceprevir and cyclosporine and tacrolimus in healthy volunteers

    Hepatology

    Volume 56, Issue 5, November 2012, Pages: 1622–1630, Ellen Hulskotte, Samir Gupta, Fengjuan Xuan, Marga van Zutven, Edward O'Mara, Hwa-Ping Feng, John Wagner and Joan Butterton

    Version of Record online : 14 OCT 2012, DOI: 10.1002/hep.25831

  3. Triple therapy with boceprevir or telaprevir in a European cohort of cirrhotic HIV/HCV genotype 1-coinfected patients

    Liver International

    Volume 35, Issue 9, September 2015, Pages: 2090–2099, Patrick Miailhes, Camille Gilbert, Karine Lacombe, Joop E. Arends, Massimo Puoti, Jürgen K. Rockstroh, Philippe Sogni, Hélène Fontaine, Eric Rosenthal, Maria Winnock, Marc-Arthur Loko, Linda Wittkop, François Dabis, Dominique Salmon and the ESCMID European Study Group on Viral Hepatitis

    Version of Record online : 23 FEB 2015, DOI: 10.1111/liv.12799

  4. Safety and efficacy of triple therapy with peginterferon, ribavirin and boceprevir within an early access programme in Spanish patients with hepatitis C genotype 1 with severe fibrosis: SVRw12 analysis

    Liver International

    Volume 35, Issue 1, January 2015, Pages: 90–100, Jose L. Calleja, Juan M. Pascasio, Belén Ruiz-Antorán, Francisco Gea, Rafael Bárcena, Juan R. Larrubia, Ramón Pérez-Álvarez, Jose M. Sousa, Manuel Romero-Gómez, Ricard Solá, Juan de la Revilla, Javier Crespo, Jose M. Navarro, Juan I. Arenas, Manuel Delgado, Conrado M. Fernández-Rodríguez, Ramon Planas, Maria Buti, Xavier Forns and the Spanish Group for the Study of the Use of Direct-Acting Drugs Hepatitis C with Severe Fibrosis

    Version of Record online : 15 SEP 2014, DOI: 10.1111/liv.12656

  5. A practical guide for the use of boceprevir and telaprevir for the treatment of hepatitis C

    Journal of Viral Hepatitis

    Volume 19, Issue s2, May 2012, Pages: 1–26, I. M. Jacobson, J.-M. Pawlotsky, N. H. Afdhal, G. M. Dusheiko, X. Forns, D. M. Jensen, F. Poordad and J. Schulz

    Version of Record online : 8 MAR 2012, DOI: 10.1111/j.1365-2893.2012.01590.x

  6. You have free access to this content
    How to optimize HCV therapy in genotype 1 patients with cirrhosis

    Liver International

    Volume 33, Issue s1, February 2013, Pages: 46–55, Marc Bourlière, Astrid Wendt, Hélène Fontaine, Christophe Hézode, Stanislas Pol and Jean Pierre Bronowicki

    Version of Record online : 3 JAN 2013, DOI: 10.1111/liv.12067

  7. Boceprevir: A Novel NS3/4 Protease Inhibitor for the Treatment of Hepatitis C

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 32, Issue 2, February 2012, Pages: 173–190, Olga M. Klibanov, Stephen B. Vickery, Jacqueline L. Olin, Lisa S. Smith and Shannon H. Williams

    Version of Record online : 30 JAN 2012, DOI: 10.1002/PHAR.1046

  8. Mutations selected in the hepatitis C virus NS3 protease domain during sequential treatment with boceprevir with and without pegylated interferon alfa-2b

    Journal of Viral Hepatitis

    Volume 19, Issue 2, February 2012, Pages: 120–127, J. Vermehren, S. Susser, C. M. Lange, N. Forestier, U. Karey, E. Hughes, R. Ralston, X. Tong, S. Zeuzem and C. Sarrazin

    Version of Record online : 1 MAR 2011, DOI: 10.1111/j.1365-2893.2011.01449.x

  9. You have free access to this content
    Optimal treatment with boceprevir for chronic HCV infection

    Liver International

    Volume 33, Issue s1, February 2013, Pages: 14–22, Benjamin Maasoumy and Michael P. Manns

    Version of Record online : 3 JAN 2013, DOI: 10.1111/liv.12070

  10. Treatment adherence and virological response rates in hepatitis C virus infected persons treated with sofosbuvir-based regimens: results from ERCHIVES

    Liver International

    Adeel A. Butt, Peng Yan, Obaid S. Shaikh, Raymond T. Chung, Kenneth E. Sherman and for the ERCHIVES study

    Version of Record online : 24 MAR 2016, DOI: 10.1111/liv.13103

  11. eGFR decrease during antiviral C therapy with first generation protease inhibitors: a clinical significance?

    Liver International

    Volume 35, Issue 1, January 2015, Pages: 71–78, Véronique Loustaud-Ratti, Annick Rousseau, Paul Carrier, Chanlina Vong, Tristan Chambaraud, Jérémie Jacques, Marilyne Debette-Gratien, Denis Sautereau and Marie Essig

    Version of Record online : 27 JUL 2014, DOI: 10.1111/liv.12631

  12. You have free access to this content
    Triple therapy for HCV genotype 1 infection: telaprevir or boceprevir?

    Liver International

    Volume 32, Issue s1, February 2012, Pages: 54–60, Mitchell L. Shiffman and Rafael Esteban

    Version of Record online : 29 DEC 2011, DOI: 10.1111/j.1478-3231.2011.02718.x

  13. You have free access to this content
    Treating HCV in HIV 2013: on the cusp of change

    Liver International

    Volume 34, Issue s1, February 2014, Pages: 53–59, Valérie Martel-Laferrière and Douglas T. Dieterich

    Version of Record online : 23 DEC 2013, DOI: 10.1111/liv.12396

  14. You have free access to this content
    How to optimize HCV therapy in genotype 1 patients: management of side-effects

    Liver International

    Volume 33, Issue s1, February 2013, Pages: 30–34, Angeli Chopra, Patricia L. Klein, Thia Drinnan and Samuel S. Lee

    Version of Record online : 3 JAN 2013, DOI: 10.1111/liv.12080

  15. Sofosbuvir-based regimens in clinical practice achieve SVR rates closer to clinical trials: results from ERCHIVES

    Liver International

    Volume 36, Issue 5, May 2016, Pages: 651–658, Adeel A. Butt, Peng Yan, Obaid S. Shaikh, Raymond T. Chung, Kenneth E. Sherman and For the ERCHIVES study

    Version of Record online : 25 DEC 2015, DOI: 10.1111/liv.13036

  16. Plasma apolipoprotein H limits HCV replication and associates with response to NS3 protease inhibitors-based therapy

    Liver International

    Volume 35, Issue 7, July 2015, Pages: 1833–1844, Philippe Sultanik, Vincent Mallet, Sylvie Lagaye, Armanda Casrouge, Céline Dorival, Yoann Barthe, Hélène Fontaine, Christophe Hézode, Estelle Mottez, Jean-Pierre Bronowicki, Fabrice Carrat, Ioannis Theodorou, Laurent Abel, Etienne Gayat, Arnaud Fontanet, Stanislas Pol, Matthew L. Albert and on behalf of ANRS CO20-CUPIC

    Version of Record online : 23 JAN 2015, DOI: 10.1111/liv.12759

  17. You have free access to this content
    HCV Therapeutics: Approved Agents

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 1091A–1168A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26880

  18. You have free access to this content
    How to optimize current therapy of HCV genotype 1 infection with boceprevir

    Liver International

    Volume 34, Issue s1, February 2014, Pages: 4–10, Marc Bourlière, Xavier Adhoute, Astrid Wendt, Christelle Ansaldi, Valérie Oules and Paul Castellani

    Version of Record online : 23 DEC 2013, DOI: 10.1111/liv.12390

  19. You have free access to this content
    HCV therapy in HIV-infected patients

    Liver International

    Volume 33, Issue s1, February 2013, Pages: 63–67, Mark S. Sulkowski

    Version of Record online : 3 JAN 2013, DOI: 10.1111/liv.12082

  20. You have free access to this content
    British HIV Association guidelines for the management of hepatitis viruses in adults infected with HIV 2013

    HIV Medicine

    Volume 14, Issue S4, November 2013, Pages: 1–71, Writing Group, Dr Ed Wilkins, Dr Mark Nelson, Dr Kosh Agarwal, Ms Dola Awoyemi, Dr Eleanor Barnes, Dr Sanjay Bhagani, Dr Gary Brook, Dr Ashley Brown, Ms Sheena Castelino, Dr Graham Cooke, Prof Martin Fisher, Prof Anna Maria Geretti, Mr Robert James, Dr Ranjababu Kulasegaram, Prof Clifford Leen, Prof David Mutimer, Dr Chloe Orkin, Dr Emma Page, Dr Adrian Palfreeman, Dr Padmasayee Papineni, Dr Alison Rodger and Dr CY William Tong

    Version of Record online : 25 OCT 2013, DOI: 10.1111/hiv.12106